Social Cognitive Theory-Based Education for Improving Health Outcomes in Older Adults (SCT-OLD)
Effect of a Social Cognitive Theory-Based Education Program on Self-Efficacy, Healthy Lifestyle Behaviors, and Health Literacy in Older Adults Attending Primary Care Centers: A Randomized Controlled Trial
Studie Overzicht
Toestand
Interventie / Behandeling
Gedetailleerde beschrijving
This study is designed as a randomized controlled trial to evaluate the impact of a Social Cognitive Theory-based educational intervention on self-efficacy, healthy lifestyle behaviors, and health literacy among older adults. The study will be conducted in a primary care setting and will include individuals aged 65 years and older who meet the inclusion criteria and provide informed consent.
Participants will be randomly assigned to either the intervention group or the control group. The intervention group will receive a structured education program based on Social Cognitive Theory, delivered in three weekly face-to-face sessions, each lasting approximately 30 minutes. The content of the program includes health promotion, healthy nutrition, physical activity, chronic disease management, self-efficacy enhancement, and health literacy improvement. The control group will receive routine primary care services without additional intervention.
Data will be collected at two time points: baseline (pre-test) and 4-6 weeks after the completion of the intervention (post-test). Outcome measures include self-efficacy, assessed using the General Self-Efficacy Scale; healthy lifestyle behaviors, assessed using the Health-Promoting Lifestyle Profile; and health literacy, assessed using the Health Literacy Scale (short form).
The study is expected to provide evidence on the effectiveness of theory-based educational interventions in promoting health behaviors and improving health literacy among older adults in primary care settings.
Studietype
Inschrijving (Werkelijk)
Fase
- Niet toepasbaar
Contacten en locaties
Studie Locaties
-
-
Van
-
Van, Van, Turkije (Türkiye), 65100
- Tuşba Bardakçı Family Health Center
-
-
Deelname Criteria
Geschiktheidscriteria
Leeftijden die in aanmerking komen voor studie
- Oudere volwassene
Accepteert gezonde vrijwilligers
Beschrijving
Inclusion Criteria:
- Aged 65 years and older
- Able to communicate in Turkish
- Willing to participate and provide informed consent
- Having sufficient cognitive ability to follow the education program
Exclusion Criteria:
- Severe cognitive impairment
- Severe psychiatric disorder
- Acute or life-threatening medical condition
Studie plan
Hoe is de studie opgezet?
Ontwerpdetails
- Primair doel: Preventie
- Toewijzing: Gerandomiseerd
- Interventioneel model: Parallelle opdracht
- Masker: Geen (open label)
Wapens en interventies
Deelnemersgroep / Arm |
Interventie / Behandeling |
|---|---|
|
Experimenteel: Intervention Group
Participants in this group will receive a structured Social Cognitive Theory-based education program consisting of three weekly face-to-face sessions, in addition to routine primary care services.
|
A structured face-to-face education program based on Social Cognitive Theory, delivered in three weekly sessions covering health promotion, nutrition, physical activity, self-efficacy, and health literacy.
|
|
Geen tussenkomst: Arm Type: Control Group (No Intervention)
Participants in this group will receive routine primary care services without any additional educational intervention.
|
Wat meet het onderzoek?
Primaire uitkomstmaten
Uitkomstmaat |
Maatregel Beschrijving |
Tijdsspanne |
|---|---|---|
|
Self-Efficacy Level
Tijdsspanne: Baseline and 4-6 weeks after intervention
|
Self-efficacy will be assessed using the General Self-Efficacy Scale (GSES).
The scale consists of 10 items scored on a 4-point Likert scale (1-4), with a total score ranging from 10 to 40.
Higher scores indicate higher levels of self-efficacy (better outcome).
|
Baseline and 4-6 weeks after intervention
|
|
Healthy Lifestyle Behaviors
Tijdsspanne: Baseline and 4-6 weeks after intervention
|
Healthy lifestyle behaviors will be measured using the Health-Promoting Lifestyle Profile II (HPLP-II).
The scale includes 52 items rated on a 4-point Likert scale (1-4), with total scores ranging from 52 to 208.
Higher scores indicate more positive health-promoting lifestyle behaviors (better outcome).
|
Baseline and 4-6 weeks after intervention
|
|
Health Literacy Level
Tijdsspanne: Baseline and 4-6 weeks after intervention
|
Health literacy will be assessed using the Health Literacy Scale-Short Form (HLS-SF).
The scale consists of items rated on a Likert-type scale, with total scores ranging from 0 to 50.
Higher scores indicate higher health literacy levels (better outcome).
|
Baseline and 4-6 weeks after intervention
|
Medewerkers en onderzoekers
Sponsor
Publicaties en nuttige links
Algemene publicaties
- Nutbeam D. Health literacy as a public health goal: 25 years on. Health Promot Int. 2025 Jul 1;40(4):daaf119. doi: 10.1093/heapro/daaf119. No abstract available.
- Sorensen K, Pelikan JM, Rothlin F, Ganahl K, Slonska Z, Doyle G, Fullam J, Kondilis B, Agrafiotis D, Uiters E, Falcon M, Mensing M, Tchamov K, van den Broucke S, Brand H; HLS-EU Consortium. Health literacy in Europe: comparative results of the European health literacy survey (HLS-EU). Eur J Public Health. 2015 Dec;25(6):1053-8. doi: 10.1093/eurpub/ckv043. Epub 2015 Apr 5.
Studie record data
Bestudeer belangrijke data
Studie start (Werkelijk)
Primaire voltooiing (Werkelijk)
Studie voltooiing (Werkelijk)
Studieregistratiedata
Eerst ingediend
Eerst ingediend dat voldeed aan de QC-criteria
Eerst geplaatst (Werkelijk)
Updates van studierecords
Laatste update geplaatst (Werkelijk)
Laatste update ingediend die voldeed aan QC-criteria
Laatst geverifieerd
Meer informatie
Termen gerelateerd aan deze studie
Trefwoorden
Aanvullende relevante MeSH-voorwaarden
Andere studie-ID-nummers
- 2026-228384
Plan Individuele Deelnemersgegevens (IPD)
Bent u van plan om gegevens van individuele deelnemers (IPD) te delen?
Informatie over medicijnen en apparaten, studiedocumenten
Bestudeert een door de Amerikaanse FDA gereguleerd geneesmiddel
Bestudeert een door de Amerikaanse FDA gereguleerd apparaatproduct
Deze informatie is zonder wijzigingen rechtstreeks van de website clinicaltrials.gov gehaald. Als u verzoeken heeft om uw onderzoeksgegevens te wijzigen, te verwijderen of bij te werken, neem dan contact op met register@clinicaltrials.gov. Zodra er een wijziging wordt doorgevoerd op clinicaltrials.gov, wordt deze ook automatisch bijgewerkt op onze website .